Welcome to brand new Ask the Fish. Post your questions in different boards to get in touch with CTisus team & Dr. Elliot K. Fishman!
Our old Ask the Fish forum can be still viewed as an archive at https://ctisus.com/redesign-askfish/index.html.
We encourage all the users to register in this new forum to get answers to their questions since the posts in old forum will no longer be reviewed!
Thank you for visiting & looking forward to your feedback!

Author Topic: Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.  (Read 3754 times)

Lilly Kauffman

  • Global Moderator
  • Newbie
  • *****
  • Posts: 34
    • View Profile
    • CTisus
Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Radiology. 2019 Jan;290(1):9-22. doi: 10.1148/radiol.2018181349. Epub 2018 Nov 20.
Nishino M1, Hatabu H1, Hodi FS1.


Cancer immunotherapy using immune-checkpoint inhibitors has emerged as an effective treatment option for a variety of advanced cancers in the past decade. Because of the distinct mechanisms of immunotherapy that activate the host immunity to treat cancers, unconventional immune-related phenomena are encountered in terms of tumor response and progression, as well as drug toxicity. Imaging plays an important role in objectively characterizing immune-related tumor responses and progression and in detecting and monitoring immune-related adverse events. Moreover, emerging data suggest a promise for molecular imaging that can visualize the specific target molecules involved in immune-checkpoint pathways. In this article, the background and current status of cancer immunotherapy are summarized, and the current methods for imaging evaluations of immune-related responses and toxicities are reviewed along with their limitations and pitfalls. Emerging approaches with molecular imaging are also discussed as a future direction to address unmet needs.

DOI: https://doi.org/10.1148/radiol.2018181349


What are your thoughts?  Comments?